Target intelligence / Profile preview

Lysine 99 of humanized catalytic antibody 38C2 heavy chain (h38C2 Lys99)

Target
h38C2 Lys99
Molecular classification
Catalytic antibody, Enzyme-mimetic antibody, Immunoglobulin heavy chain, Abzyme
01

Overview

Lysine 99 of the humanized catalytic antibody 38C2 (h38C2) heavy chain is a highly specialized amino acid residue located at the base of a deep, hydrophobic binding pocket in the variable heavy (VH) domain. This residue is distinguished by an exceptionally low pKa of approximately 6.0, which is significantly lower than the typical pKa of ~10.5 for lysine side chains, making it a potent nucleophile at physiological pH (Wagner et al., 1995; Rader et al., 2003). This unique chemical environment allows the lysine to function as a catalytic center, mimicking the mechanism of Class I aldolases by forming covalent Schiff base intermediates with carbonyl-containing substrates (Sinha et al., 2004). In the field of bioconjugation and drug delivery, this residue serves as the primary site for "chemical programming," where small molecule ligands or prodrugs equipped with 1,3-diketone or beta-lactam functional groups are covalently and site-specifically attached to the antibody (Popkov et al., 2009). This technology, known as Chemically Programmed Antibodies (cpAbs), enables the creation of therapeutic agents that combine the targeting precision of small molecules with the favorable pharmacokinetics and effector functions of a humanized monoclonal antibody.

Other names
LysH93 (Kabat numbering)Reactive lysine of h38C2Aldolase antibody 38C2 active siteVH Lys99h38C2-reactive lysine
02

Mechanism of action

Covalent conjugation via the formation of a stable enaminedione or Schiff base between the nucleophilic epsilon-amino group of Lys99 and a carbonyl-containing linker (e.g., 1,3-diketone).

03

Biological functions

Aldol catalysisCovalent bioconjugationSchiff base formationEnamine mechanism catalysis
04

Disease associations

CancerInflammationInfectious disease
05

Safety considerations

Immunogenicity of the humanized antibody scaffoldPotential off-target reactivity with endogenous electrophilesStability of the covalent bond in vivo
06

Interacting drugs

SCS-873

3 more in the full profile.

07

Biomarkers

Antibody-drug conjugate (ADC) serum levelsCatalytic activity of h38C2

Beyond the preview

Go deeper on Lysine 99 of humanized catalytic antibody 38C2 heavy chain (h38C2 Lys99).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lysine 99 of humanized catalytic antibody 38C2 heavy chain (h38C2 Lys99).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call